JP2000516805A - CS4―CFA/Iファミリータンパク質を有するE.coliを凝集させるモノクローナル抗体 - Google Patents
CS4―CFA/Iファミリータンパク質を有するE.coliを凝集させるモノクローナル抗体Info
- Publication number
- JP2000516805A JP2000516805A JP10508058A JP50805898A JP2000516805A JP 2000516805 A JP2000516805 A JP 2000516805A JP 10508058 A JP10508058 A JP 10508058A JP 50805898 A JP50805898 A JP 50805898A JP 2000516805 A JP2000516805 A JP 2000516805A
- Authority
- JP
- Japan
- Prior art keywords
- cfa
- composition
- coli
- antibody
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/10—Enterobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/245—Escherichia (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.ハイブリドーマ96-109FE8 IH11によって産生されるモノクローナル抗体であ って、CS4-CFA/Iファミリータンパク質を有する細菌を凝集させ、排他的および 特異的に配列SAVALTYSに結合する、モノクローナル抗体。 2.ハイブリドーマ96-109FE8 IH11によって産生される、請求項1に記載のモノ クローナル抗体。 3.細菌含有増殖培地への適用のために適切なキャリア中に請求項1に記載のモ ノクローナル抗体を含む物質の組成物。 4.前記モノクローナル抗体が抗体/CS4-CFA/Iファミリータンパク質複合体の 同定を補助するためにタグを有する、請求項3に記載の組成物。 5.前記タグが蛍光発生薬剤である、請求項4に記載の組成物。 6.前記タグが比色定量用タグである、請求項4に記載の組成物。 7.CS4-CFA/Iファミリータンパク質を有する生物の存在を検出するためのアッ セイであって: 1.生物の培養物を請求項1に記載の組成物と接触させる抗体、 2.請求項1に記載の組成物中のモノクローナル抗体が微生物と相互作用する ように時間を経過させる工程、および 3.工程2の相互作用の後に培養物を検査して、CS4-CFA/Iファミリータンパ ク質/抗体複合体が形成されているかどうかを決定する工程、 を包含する、アッセイ。 8.薬学的に受容可能なキャリア中に請求項1に記載の抗体を含む組成物。 9.前記キャリアが生理食塩水である、請求項8に記載の組成物。 10.細菌凝集有効量の請求項8に記載の組成物の投与による、CF4-CFA/Iファ ミリータンパク質を有する細菌での感染から生じる病気を処置する方法。 11.細菌凝集有効量の請求項8に記載の組成物の投与による、CF4-CFA/Iファ ミリータンパク質を有する細菌での感染から生じる病気に対して予防する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2307596P | 1996-08-02 | 1996-08-02 | |
US60/023,075 | 1996-08-02 | ||
PCT/US1997/013477 WO1998005687A1 (en) | 1996-08-02 | 1997-08-01 | Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000516805A true JP2000516805A (ja) | 2000-12-19 |
JP2000516805A5 JP2000516805A5 (ja) | 2005-04-07 |
Family
ID=21812990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10508058A Pending JP2000516805A (ja) | 1996-08-02 | 1997-08-01 | CS4―CFA/Iファミリータンパク質を有するE.coliを凝集させるモノクローナル抗体 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0918796B1 (ja) |
JP (1) | JP2000516805A (ja) |
CA (1) | CA2262819C (ja) |
DE (1) | DE69737233D1 (ja) |
WO (1) | WO1998005687A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7094883B1 (en) * | 1996-08-02 | 2006-08-22 | The United States Of America As Represented By The Secretary Of The Army | Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein |
US7404961B2 (en) * | 1996-08-02 | 2008-07-29 | The United States Of America As Represented By The Secretary Of The Army | Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins |
EP0969018A1 (en) * | 1998-07-02 | 2000-01-05 | Combact Diagnostic Systems Ltd. | Anti bacterial monoclonal antibodies |
US6689572B1 (en) * | 2000-10-13 | 2004-02-10 | Executive Yuan, Council Of Agriculture | E. coli agglutination assay |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992001703A1 (en) * | 1990-07-24 | 1992-02-06 | Emory University | Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes |
US5914114A (en) * | 1995-06-02 | 1999-06-22 | The United States Of America As Represented By The Secretary Of The Army | Method of raising antibodies against E. coli of the family CS4-CFA/I |
-
1997
- 1997-08-01 CA CA2262819A patent/CA2262819C/en not_active Expired - Fee Related
- 1997-08-01 WO PCT/US1997/013477 patent/WO1998005687A1/en active IP Right Grant
- 1997-08-01 EP EP97938077A patent/EP0918796B1/en not_active Expired - Lifetime
- 1997-08-01 DE DE69737233T patent/DE69737233D1/de not_active Expired - Lifetime
- 1997-08-01 JP JP10508058A patent/JP2000516805A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0918796B1 (en) | 2007-01-10 |
CA2262819C (en) | 2011-10-04 |
WO1998005687A1 (en) | 1998-02-12 |
EP0918796A1 (en) | 1999-06-02 |
EP0918796A4 (en) | 2002-11-06 |
DE69737233D1 (de) | 2007-02-22 |
CA2262819A1 (en) | 1998-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5196337A (en) | Human monoclonal antibody, and its production and use | |
KR0165691B1 (ko) | 장출혈성 대장균 015:h7 및 026:h11에 대한 단일클론 항체 및 검출 방법 | |
Abraham et al. | Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors | |
US4683196A (en) | Method and materials for the identification of lipopolysaccharide producing microorganisms | |
US5378812A (en) | Monoclonal antibodies cross-reactive and cross-protective against P. aeruginosa serotypes | |
JPH07501210A (ja) | Moraxella catarrhalisの有用な抗原に関する方法と組成 | |
EP0341684B1 (en) | Human monoclonal antibody, hybridoma producing the same and pharmaceutical | |
JPH05304990A (ja) | マイコプラズマ・ニウモニアエに対するモノクローナル抗体 | |
EP0168422A1 (en) | Method and materials for the identification of lipopolysaccharide producing microorganisms | |
WO1986001805A1 (en) | Monoclonal antibodies and their use | |
EP0176365B1 (en) | Human monoclonal antibody and its preparation | |
WO1986001806A1 (en) | Monoclonal antibodies and their use | |
JP2000516805A (ja) | CS4―CFA/Iファミリータンパク質を有するE.coliを凝集させるモノクローナル抗体 | |
WO1986000993A1 (en) | A salmonella-specific analyses reagent | |
US7094883B1 (en) | Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein | |
Pongsunk et al. | Production of specific monoclonal antibodies to Burkholderia pseudomallei and their diagnostic application | |
EP0326148A1 (en) | Human monoclonal antibody specific for Pseudomonas aeruginosa and hybrid cell lines | |
JP2587770B2 (ja) | 形質転換細胞 | |
WO1986002360A1 (en) | Monoclonal antibodies and their use | |
Albert et al. | Characterization of Aeromonas caviae antigens which cross-react with Shigella boydii 5 | |
WO1987000534A1 (en) | Monoclonal antibodies and their use | |
JPH01193300A (ja) | ヒトモノクローナル抗体およびその製法 | |
JPS62502284A (ja) | 抗原的に活性な蛋白質及び淋病の診断におけるその使用 | |
WO1986000644A1 (en) | Monoclonal antibodies and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040727 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040727 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080507 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080806 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091020 |